Pharmacology
Mechanism of Action
Lipoglycopeptide antibiotic that is a synthetic derivative of vancomycin
Inhibits bacterial cell wall synthesis by interfering with polymerization and cross-linking of peptidoglycan
Unlike vancomycin, telavancin also depolarizes the bacterial cell membrane and disrupts its functional integrity
Absorption
Poor oral absorption
Distribution
Protein Bound: 90%
Vd: 133-145 mL/kg
Metabolism
Metabolic pathway not yet identified; not metabolized by CYP450 isoenzymes
Elimination
Half-life: 8 hr
Clearance: 13.1-13.9 mL/hr/kg
Excretion: 75% urine;